COMMUNIQUÉS West-GlobeNewswire

Allogene Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
MORRIS PLAINS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced [...]
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain
19/12/2018
Topline data readout expected in mid-2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and [...]
CardioDx Presents Comparative Effectiveness Claims Analysis Highlighting the Clinical Value of the Corus® CAD Precision Medicine Blood Test in Elderly Patients at the Gerontological Society of America 2018 Annual Meeting
19/12/2018
Corus CAD Blood Test Was Associated With Decreased Downstream CAD-Related Healthcare Utilization in the Real-World Study of Elderly Patients Evaluated for Suspected Coronary Artery Disease REDWOOD CITY, Calif., Dec. 19 [...]
Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern
19/12/2018
FREEHOLD, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced that it will ring The Nasdaq Stock Market [...]
AzurRx BioPharma Announces Initiation of Phase II OPTION Clinical Trial of MS1819-SD in Cystic Fibrosis Patients
19/12/2018
First site initiated at the Cystic Fibrosis Institute Initial top line data expected in 2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company [...]
KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio
19/12/2018
CELEBRATION, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today provided a corporate update [...]
Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN™ (macimorelin) in the United States and Canada
19/12/2018
Strongbridge Used Portion of $145 Million Upfront Cash Payment from Novo Nordisk to Fully Repay Outstanding Debt DUBLIN, Ireland and TREVOSE, Pa., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: [...]
Radient Technologies Inc. Files Provisional Applications for Innovating Cannabinoid-Infused Food & Beverage Manufacturing Processes
19/12/2018
EDMONTON, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has now filed an additional 9 provisional [...]
Mesoblast Makes Executive Appointment to Drive Product Commercialization
19/12/2018
NEW YORK and MELBOURNE, Australia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that it has appointed Eric Strati, PhD, to the new position of Senior Vice President, [...]
Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader
19/12/2018
Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres; Aleafia patients to access Emblem’s differentiated, high margin derivative products [...]
Loop Industries and thyssenkrupp Sign Global Alliance Agreement to Transform the Future of Sustainable Pet Plastic Manufacturing
19/12/2018
Global Alliance Agreement aims to combine Loop Industries’ depolymerization technology with thyssenkrupp Industrial Solutions’ PET Melt-To-Resin® technology Integration of technologies is intended to provide rapidly [...]
Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia
19/12/2018
Auransa to Receive Upfront Payment and be Eligible for Milestone Payments and Sales Royalties for Preclinical Program Identified by Company’s AI-Driven SMarTR™ Engine China Oncology Focus to Receive Rights to Develop [...]
EndoPredict® Test Receives Positive NICE Recommendation for Patients with Early Breast Cancer
19/12/2018
NICE Decision is a Major Milestone in Expanding Access to Patients in the UK SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]
Dengvaxia® vaccine approved for prevention of dengue in Europe
19/12/2018
Dengvaxia ® vaccine approved for prevention of dengue in Europe Paris, France - December 19, 2018 - The European Commission has granted marketing authorization for Dengvaxia ® , Sanofi's dengue vaccine. The marketing [...]
Le vaccin Dengvaxia® est approuvé en Europe pour la prévention de la dengue
19/12/2018
Le vaccin Dengvaxia ® est approuvé en Europe pour la prévention de la dengue Paris, France - Le 19 décembre 2018 - La Commission européenne a délivré une autorisation de mise sur le marché de Dengvaxia ® , le vaccin de [...]
AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR RD 01 for the Treatment of Fabry Disease
19/12/2018
CAMBRIDGE, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company developing gene therapies to potentially cure rare diseases with a single [...]
IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor
19/12/2018
WINTER SPRINGS, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced FDA 510(k) [...]
Canopy Rivers Announces DTC Eligibility
19/12/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) is pleased to announce that its [...]

Pages